SCHEMBL21111151

SCHEMBL21111151

CN1C(=O)C(N(C(=O)O)C(C)(C)C)COc2ccc(C(=O)NCCC#N)cc21

nearest known ligand 0.42

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 1/20 0.42
RIPK1 Q13546 15/20 0.38
DRD2 P14416 3/20 0.34
DRD3 P35462 3/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21111150 1.00 USP30 (0.42) USP30RIPK1DRD2DRD3KMT2A
SCHEMBL21111282 0.85 RIPK1 (0.41) USP30RIPK1
SCHEMBL21111285 0.85 RIPK1 (0.41) USP30RIPK1
SCHEMBL19980292 0.82 USP30 (0.47) USP30RIPK1DRD2DRD3KMT2A
SCHEMBL18409596 0.80 RIPK1 (0.41) RIPK1
SCHEMBL18409597 0.80 RIPK1 (0.41) RIPK1
SCHEMBL15964689 0.79 RIPK1 (0.43) USP30RIPK1
SCHEMBL17312486 0.78 RIPK1 (0.41) RIPK1
SCHEMBL17312488 0.78 RIPK1 (0.41) RIPK1
SCHEMBL17312429 0.76 KIF11 (0.40) RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3508484-A1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS GlaxoSmithKline Intellectual Property Development Limited (GB) 2019-07-10 EP disclosed